scholarly journals Robotic Assisted Flexible Ureteroscopy in Covid-19 Positive Patient Using Thulium Fiber Laser: Case Report and Literature Review

2021 ◽  
Vol 1 (1) ◽  
pp. 03-06
Author(s):  
Abdulla Al-Ansari ◽  
Maged Alrayashi ◽  
Hatem Kamkoum ◽  
Hossameldin Alnawsara ◽  
Bela Tallai ◽  
...  

Flexible Ureteroscopy (FURS) has become an integral aspect of the surgical armamentarium to treat intra-renal stones that are less than 2 cm in diameter. Despite the progress made with regards to the design of the flexible ureteroscopes, surgeons still need to work with suboptimal ergonomics, which may result in orthopedic complaints, which as a result lead to imperfect performance. Robotic- Assisted FURS with Avicenna Roboflex has provided significant improvement of ergonomics. The Super Pulse Thulium Fiber Laser (SPTFL) may be considered as a viable alternative to holmium laser in stone management. Coronavirus Disease- 19 (Covid-19) has been declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. As a result, many hospitals have been converted to dedicated facilities to manage the Covid-19 patients. Urinary stone disease represents a benign condition, but in non-negligible number of cases, it can lead to potential severe septic complications that could increase the burden on emergency services. Many surgical specialties including urology has made short pathways for patient flow to decrease the contact with the patients which in turn will decrease the possibility of transmission of Covid-19. The use of new technologies such as Avicenna Roboflex and thulium fiber laser in Covid-19 positive patients when performing flexible ureteroscopy can minimize direct contact with the patient, expedite the procedure, while protecting the staff from getting Covid-19 infection.

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Etienne Xavier Keller* ◽  
Vincent De Coninck ◽  
Viktoriya Vinnichenko ◽  
Paul Chiron ◽  
Steeve Doizi ◽  
...  

Urologiia ◽  
2020 ◽  
Vol 6_2020 ◽  
pp. 89-92
Author(s):  
L.M. Rapoport Rapoport ◽  
M.A. Gazimiev Gazimiev ◽  
D.O. Korolev Korolev ◽  
D.G. Tsarichenko Tsarichenko ◽  
YU.A. Svetikova Svetikova ◽  
...  

2018 ◽  
Vol 17 (7) ◽  
pp. e2354 ◽  
Author(s):  
L. Rapoport ◽  
P. Glybochko ◽  
D. Enikeev ◽  
D. Tsarichenko ◽  
B. Johnson ◽  
...  

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Antonio Bernabé-Ortiz ◽  
Jessica H. Zafra-Tanaka ◽  
Miguel Moscoso-Porras ◽  
Rangarajan Sampath ◽  
Beatrice Vetter ◽  
...  

AbstractA key component of any health system is the capacity to accurately diagnose individuals. One of the six building blocks of a health system as defined by the World Health Organization (WHO) includes diagnostic tools. The WHO’s Noncommunicable Disease Global Action Plan includes addressing the lack of diagnostics for noncommunicable diseases, through multi-stakeholder collaborations to develop new technologies that are affordable, safe, effective and quality controlled, and improving laboratory and diagnostic capacity and human resources. Many challenges exist beyond price and availability for the current tools included in the Package of Essential Noncommunicable Disease Interventions (PEN) for cardiovascular disease, diabetes and chronic respiratory diseases. These include temperature stability, adaptability to various settings (e.g. at high altitude), need for training in order to perform and interpret the test, the need for maintenance and calibration, and for Blood Glucose Meters non-compatible meters and test strips. To date the issues surrounding access to diagnostic and monitoring tools for noncommunicable diseases have not been addressed in much detail. The aim of this Commentary is to present the current landscape and challenges with regards to guidance from the WHO on diagnostic tools using the WHO REASSURED criteria, which define a set of key characteristics for diagnostic tests and tools. These criteria have been used for communicable diseases, but so far have not been used for noncommunicable diseases. Diagnostic tools have played an important role in addressing many communicable diseases, such as HIV, TB and neglected tropical diseases. Clearly more attention with regards to diagnostics for noncommunicable diseases as a key component of the health system is needed.


2020 ◽  
Vol 19 ◽  
pp. e350
Author(s):  
D. Enikeev ◽  
M. Taratkin ◽  
Y. Alyaev ◽  
L. Rapoport ◽  
D. Korolev ◽  
...  

2017 ◽  
Vol 16 (3) ◽  
pp. e2112 ◽  
Author(s):  
P.A. Geavlete ◽  
R. Saglam ◽  
D. Georgescu ◽  
R. Multescu ◽  
V. Mirciulescu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document